Gyroscope Capital Management Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,600
Closed -$277K 170
2022
Q4
$277K Buy
+3,600
New +$274K 0.08% 119
2019
Q1
Sell
-24,153
Closed -$1.08M 133
2018
Q4
$1.08M Buy
+24,153
New +$1.26M 0.41% 54
2017
Q3
Sell
-68,724
Closed -$5.36M 113
2017
Q2
$5.36M Buy
68,724
+6,808
+11% +$514K 2.68% 18
2017
Q1
$5.05M Buy
61,916
+11,698
+23% +$921K 3.03% 17
2016
Q4
$3.61M Sell
50,218
-1,628
-3% -$118K 2.42% 24
2016
Q3
$4.03M Buy
+51,846
New +$4.19M 3.01% 17

Other funds holding CAH

Gyroscope Capital Management Group's CAH Position: Q1 2023 in Review

Gyroscope Capital Management Group sold out of Cardinal Health (CAH) in Q1 2023, closing a stake of 3,600 shares — an estimated $277K sold.

Gyroscope Capital Management Group first reported a position in CAH in Q3 2016 and held it in 6 quarters. The position peaked at $5.36M in Q2 2017. 907 funds tracked by Wall St. Rank hold CAH as of Q1 2023.

  • Gyroscope Capital Management Group reported no remaining Cardinal Health position as of Q1 2023 after selling out during the quarter.
  • Gyroscope Capital Management Group sold 3,600 Cardinal Health shares in Q1 2023, an estimated $277K.
  • Gyroscope Capital Management Group first reported a position in Cardinal Health in Q3 2016 and held it in 6 quarters.
  • Gyroscope Capital Management Group's Cardinal Health position peaked at $5.36M in Q2 2017.
  • 907 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2023.

Based on Gyroscope Capital Management Group's 13F filing for Q1 2023, filed 3 May 2023.